Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway-Reference-Cited by-同舟云学术

Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway

Published:2019-01-19 Issue:1 Volume:47 Page:83-89
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Xiang Qing-Feng¹²,Zhan Mei-Xiao³,Li Yong³,Liang Hui²,Hu Cong²,Huang Yao-Ming²,Xiao Jing³,He Xu³,Xin Yong-Jie³,Chen Min-Shan¹,Lu Li-Gong³

Affiliation:

1. Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China;

2. Department of General Surgery, Zhuhai People's Hospital, Zhuhai Hospital of Jinan University, Zhuhai, China;

3. Zhuhai Interventional Medical Center, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai Hospital of Jinan University, Zhuhai, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://tandfonline.com/doi/pdf/10.1080/21691401.2018.1543195

Reference30 articles.

1. Global cancer statistics, 2012

2. Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?

3. Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 Patients

4. Hepatocellular carcinoma

5. Systemic Therapy for Hepatocellular Carcinoma: 2017 Update

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis;Frontiers in Immunology;2024-05-10

3. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL;Journal of Experimental & Clinical Cancer Research;2024-01-29

4. Radiomics Based on Contrast-Enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance;Molecular Imaging and Biology;2023-11-06

5. Radiomics Based on Contrast-enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance;2023-08-14